Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
GSK429286A
CHF 0.00
In stock
SYN-1071-M0011 mgCHF 128.00
SYN-1071-M0055 mgCHF 220.00
SYN-1071-M01010 mgCHF 326.00
SYN-1071-M05050 mgCHF 944.00
SYN-1071-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | GSK-429286A; RHO-15 |
| Product Type | Chemical |
| Properties | |
| Formula | C21H16F4N4O2 |
| MW | 432.4 |
| CAS | 864082-47-3 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: ROCK | Kinase Group: AGC | Substrate: Serine-Threonine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | OLIIUAHHAZEXEX-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
GSK429286A is a potent and selective inhibitor of Rho-associated kinase (ROCK1), with an IC(50) of 14nM. It is orally available and has been shown to dramatically reduce mean arterial pressure in spontaneously hypertensive rats.
Product References
- Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease: R.J. Nichols, et al.; Biochem. J. 424, 47 (2009)
Related Products
